4 completed. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 1 | 1 | Completed 1 |
Follow valspodar: new trials by email Literature Review of valspodar trials Research Report on valspodar
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| S9918 PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia filgrastim, sargramostim, cytarabine - Leukemia | Phase 2 | Completed | SWOG Cancer Research Network | 55 | 2000-02-01 | 2015-03-06 |
| Drug Resistance Inhibition in Treating Women With Recurrent or Metastatic Breast Cancer paclitaxel, valspodar - Breast Cancer | Phase 2 | Completed | Eastern Cooperative Oncology Group | 36 | 1997-08-14 | 2023-06-07 |
| Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Patients With Acute Myelogenous Leukemia ara-C, Daunorubicin, Etoposide - Leukemia | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 410 | 1997-02-01 | 2012-11-30 |
| Paclitaxel With or Without PSC 833 in Treating Patients With Metastatic Breast Cancer paclitaxel, valspodar - Breast Cancer | Phase 2 | Completed | City of Hope Medical Center | 70 | 1996-06-01 | 2010-01-06 |
Breast Neoplasms (2) · Leukemia (2) · Leukemia, Erythroblastic, Acute (2) · Leukemia, Megakaryoblastic, Acute (2) · Leukemia, Monocytic, Acute (2) · Leukemia, Myeloid, Acute (2) · Leukemia, Myelomonocytic, Acute (2)
City of Hope Medical Center (1) · Eastern Cooperative Oncology Group (1) · National Cancer Institute (NCI) (1) · SWOG Cancer Research Network (1)
United States (4) · Canada (2)
James H. Doroshow, MD (1) · Jonathan E. Kolitz, MD (1) · Robert W. Carlson, MD (1) · Thomas R. Chauncey, MD, PhD (1)
PMID 11331327, PMID 11585760, PMID 12750167, PMID 15514371, PMID 16275934, PMID 16670265, PMID 24383844, PMID 25527568
U01CA063265 (1), U10CA031946 (1), U10CA032102 (1)